Quantitative Faecal Hb (FHb)

Quantitative Faecal Hb (FHb)

Purpose:
The Quantitative Faecal Hb programme is available as part of a comprehensive suite of programmes to assess and monitor the performance of the Clinical Biochemistry laboratory’s repertoire of both core and esoteric tests used for the diagnosis and monitoring of disease.

In July 2017 NICE published a diagnostic guidance document (DG30) that recommended the use of Faecal Immunochemical tests (FIT) in patients presenting to primary care with low risk symptoms for colorectal cancer.

Scope:
Material is dispensed aseptically into buffered vials specific to each instrument manufacturer. The base material is organic material which closely mirrors the basic constituents of human faeces. This material is spiked with human whole blood (Hb) to cover the pathological and analytical range for Faecal Immunochemical tests (FIT).  Samples challenging clinically relevant cut-offs for both symptomatic testing pathways and screening programmes.


Key Features:

  • Material closely mirrors the basic constituents of human faeces.
  • Samples provided in instrument specific collection devices.
  • Covers the pathological and analytical range for quantitative FIT automated analysers.
  • Samples challenging clinically relevant cut-offs for both symptomatic testing pathways and screening programmes.

Samples:
3
Material:
Organic material spiked with human whole blood
Frequency:
Monthly

Quantitative Faecal Hb Programme
AnalyteApprox. Range Covered
Quantitative FIT0 - 400µg Hb/ g matrix

Related Documents

Accreditation

UKAS Proficiency Testing 4301UKAS Calibration 4301


EQA Programme Enquiry

    Forename / First Name*

    Surname / Family Name*

    Email*

    Client type*

    Weqas Lab Code (if known)

    Hospital/Organisation*

    What EQA programme are you interested in?

    Message

    *required